Optogenetic and chemogenetic insights into the neurocircuitry of depression-like behaviour: A systematic review

Tom Biselli1, Susen Sophie Lange1, Lynn Sablottny1

  • 1Biological Psychology, TU Dresden, Dresden, Germany.

Insights

Optogenetics and chemogenetics reveal causal links between specific neurons and depressive behaviors in rodents. This review identifies key brain circuits implicated in major depressive disorder (MDD) for future therapeutic strategies.

Area of Science:

  • Neuroscience
  • Behavioral Science
  • Genetics

Background:

  • Major depressive disorder (MDD) poses a significant global health challenge.
  • Optogenetics and chemogenetics offer powerful tools to investigate the neural underpinnings of MDD.
  • Rodent models are crucial for understanding the causal relationships between neuronal activity and depressive-like behaviors.

Purpose of the Study:

  • To systematically review studies using optogenetic or chemogenetic techniques in rodent models of depression.
  • To identify central neuronal mechanisms causally linked to depressive-like behavior.
  • To highlight promising future research directions for MDD treatment.

Main Methods:

  • Systematic literature search identifying 43 original studies.
  • Analysis of optogenetic and chemogenetic techniques applied to rodent models of depression.
  • Examination of identified brain structures and their causal roles in depressive-like behavior.

Main Results:

  • A complex network of brain structures, including the medial prefrontal cortex, amygdala, hippocampus, and raphe nuclei, is causally implicated in depressive-like behavior.
  • Evidence supports a role for a cortico-limbic reward circuitry in MDD neuropathology.
  • Conflicting results and methodological variations across studies were noted, impacting comparability.

Conclusions:

  • Optogenetics and chemogenetics have elucidated causal links between specific neuronal circuits and depressive-like behaviors in rodents.
  • Key brain regions involved in MDD pathophysiology have been identified, particularly within reward circuitry.
  • Future research must address methodological inconsistencies to advance understanding and therapeutic development for MDD.

Related Concept Videos

Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
400
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
730
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
752